Rankings
▼
Calendar
VSTM Q2 2016 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena
VSTM
Verastem, Inc.
$376M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$9M
Net Income
-$9M
EPS (Diluted)
$-2.78
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$95M
Total Liabilities
$6M
Stockholders' Equity
$89M
Cash & Equivalents
$40M
← FY 2016
All Quarters
Q3 2016 →